Albemarle Corporation

New York Stock Exchange
Back to all articles
Slightly Bullish +25

Scotiabank Has Lowered Expectations for Albemarle (NYSE:ALB) Stock ...

AI-generated analysis

📉 Scotiabank cut Albemarle's price target to $200.00 from $215.00 while maintaining a 'sector outperform' rating.

📈 Wells Fargo, Citigroup, and Deutsche Bank recently raised targets or upgraded ratings, creating a mixed analyst consensus near $199.22.

💰 Albemarle reported Q1 revenue of $1.43 billion, up 32.7% year-over-year, with EPS of $2.95 beating estimates by $1.71.

📊 The company posted a positive return on equity of 5.22% despite a negative net margin of -5.00% for the quarter.

👔 CEO J Kent Masters sold 16,393 shares worth approximately $3 million in a transaction dated May 15th.

🏦 Institutional ownership remains high at 92.87%, with major funds like AQR Capital and Integrated Wealth Concepts increasing stakes.

⚗️ Albemarle operates as a leading global producer of lithium, bromine, and catalysts for electric vehicles and industrial applications.

📅 The company's last earnings announcement was released on Wednesday, May 6th, showing a turnaround from the prior year's loss.

Bullish Signals
  • Albemarle reported revenue of $1.43 billion, a significant 32.7% increase compared to the prior year period.
  • The company beat earnings per share estimates by $1.71, reporting $2.95 EPS against a consensus of $1.24.
  • Deutsche Bank increased its price target to $250.00 and assigned a 'buy' rating in May.
  • Citigroup upgraded the stock to a 'buy' rating with a $225.00 price target in June.
  • Wells Fargo raised its price objective to $200.00 and maintained an 'equal weight' rating in May.
  • Hedge fund AQR Capital Management increased its stake by 25.5% in the first quarter.
  • Integrated Wealth Concepts grew its position by 26.2% during the first quarter.
  • Institutional investors maintain a dominant 92.87% ownership stake in the company.
Risk Factors
  • Scotiabank lowered its price target from $215.00 to $200.00, indicating a reduction in near-term upside expectations.
  • The company reported a negative net margin of -5.00% for the quarter despite strong revenue growth.
  • CEO J Kent Masters sold 16,393 shares worth approximately $3 million, reducing his personal position by 15.78%.
Full Analysis
Scotiabank has lowered its price target for Albemarle (NYSE:ALB) from $215.00 to $200.00, maintaining a 'sector outperform' rating. This adjustment contrasts with recent bullish moves from other major institutions; Wells Fargo raised its target to $200.00 in May, Citigroup upgraded the stock to a 'buy' with a $225.00 target in June, and Deutsche Bank increased its target to $250.00 in May. Despite the mixed analyst sentiment, the consensus price target remains near $199.22 based on ratings from fifteen buy-side analysts. Albemarle reported strong quarterly financial results ending May 6th, with revenue of $1.43 billion representing a 32.7% year-over-year increase. The company posted earnings per share (EPS) of $2.95, significantly beating the consensus estimate of $1.24 and reversing a loss from the prior year period. While the net margin was negative at -5.00%, the return on equity remained positive at 5.22%, highlighting robust operational performance in its lithium, bromine, and catalysts divisions. Corporate governance and institutional ownership data reveal mixed signals regarding insider confidence and capital allocation. CEO J Kent Masters sold approximately $3 million worth of shares in mid-May, reducing his personal stake by roughly 16%. Conversely, hedge funds have been net buyers, with AQR Capital Management increasing its position by 25.5% and Integrated Wealth Concepts growing its stake by 26.2% in the first quarter, while institutional ownership stands at a high 92.87%.